Search for: "Elan Pharmaceuticals Inc"
Results 21 - 40
of 55
Sorted by Relevance
|
Sort by Date
13 Aug 2010, 12:46 pm
Elan Pharmaceuticals (2009-1437, -1438) precedential King acquired the patent rights from Elan. [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging novelty:… [read post]
1 Sep 2010, 4:46 pm
Eon Labs, Inc. and Elan Pharmaceuticals, Inc. at http://www.patentlyo.com/patent/2010/08/ignoring-non-patentable-elements-while-judging-novelty.html Hyatt v. [read post]
28 Jul 2010, 12:06 am
Teva Pharmaceuticals USA, Inc. [read post]
1 Nov 2007, 4:01 am
--O R D E RFor the reasons stated in the accompanying Memorandum Opinion, it is hereby ORDERED:1) Defendants' Motion to Strike Exhibit E of the Memorandum in Support of Plaintiffs' Motion for Preliminary Injunction is DENIED:2) The Motions of American Intellectual Property Law Association, HEXAS, LLC, The Roskamp Institute, Tikvah Therapeutics, Inc., and Elan Pharmaceutical Corp. for Leave to File Amici Curiae Briefs in Support of Plaintiffs' Motion for a… [read post]
2 Aug 2010, 10:23 am
Eon Labs, Inc. and Elan Pharmaceuticals, Inc. [read post]
12 Dec 2008, 8:42 am
Cir. 2006); Elan Pharms., Inc. v. [read post]
15 Jun 2011, 4:56 am
Par Pharmaceutical, Inc. [read post]
27 Mar 2014, 6:07 am
Patent-infringement case Teva Pharmaceuticals USA, Inc. v. [read post]
29 Jul 2013, 7:45 am
In In re Rigel Pharmaceuticals, Inc. [read post]
30 Jan 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: AIPLA urges Federal Circuit not to proscribe patents for biomedical diagnostic tools: Prometheus v Mayo (Inventive Step) (Hal Wegner) (Patently-O) (Holman's Biotech IP Blog) Lovenox (Enoxaparin) – US: Aventis files for certiorari: challenging Federal Circuit’s low standard for intent to deceive in inequitable… [read post]
16 Jun 2010, 3:02 pm
Zydus Pharmaceuticals USA, Inc. et al. [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) Avinza (Morphine) – US: King Pharmaceuticals, Elan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Cipro (Ciprofloxacin) – US: California court rules that Bayer AG et al did not violate state antitrust law in Cipro reverse payment case (FDA Law Blog) Effexor (Venlafaxine) - Israel: Patent oppositions: should substance or procedural issues win out? [read post]
31 Jul 2018, 2:29 pm
Martoma’s portfolio included two pharmaceutical companies, Elan Corporation, plc (“Elan”) and Wyeth Pharmaceuticals, Inc. [read post]
31 Jul 2018, 2:29 pm
Martoma’s portfolio included two pharmaceutical companies, Elan Corporation, plc (“Elan”) and Wyeth Pharmaceuticals, Inc. [read post]
9 Mar 2011, 3:00 am
Allergan, Inc (Chicago IP Litigation Blog) Synagis (Palivizumab) – US: PDL BioPharma settles Medimmune Synagis litigation for $93M (Patent Docs) TriCor (Fenofibrate) – US: Abbott and Elan end TriCor suit with Ranbaxy (Patent Docs) Valsartan – Norway: Oslo District Court holds Actavis’ Valsartan/HCTZ product infringes Novartis’ patent covering synthesis route for Valsartan; deals inter alia with scope of Valsartan SPC (The SPC Blog) [read post]
17 Feb 2010, 5:10 am
USA, Inc; Eli Lilly & Co. v. [read post]
6 Jan 2007, 7:34 am
" For example, "the venom of a deadly sea snail found off the coast of the Philippines led Elan Pharmaceuticals Inc. to develop the painkiller Prialt, which U.S. regulators approved in 2004. [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
21 Jun 2012, 11:46 am
Teva Pharmaceuticals USA, Inc. [read post]
